BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12559127)

  • 21. Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.
    Fuentealba JA; Gysling K; Magendzo K; Andrés ME
    J Neurosci Res; 2006 Aug; 84(2):450-9. PubMed ID: 16676328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W; Neill DB; Lynn M; Justice JB
    Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice.
    van Heesch F; Prins J; Korte-Bouws GA; Westphal KG; Lemstra S; Olivier B; Kraneveld AD; Korte SM
    Behav Brain Res; 2013 Sep; 253():191-5. PubMed ID: 23896053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of sensitization to amphetamine and dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal cortex.
    Hedou G; Homberg J; Feldon J; Heidbreder CA
    Neuropharmacology; 2001 Mar; 40(3):366-82. PubMed ID: 11166330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular dopamine and its metabolites in the nucleus accumbens of Fischer and Lewis rats: basal levels and cocaine-induced changes.
    Strecker RE; Eberle WF; Ashby CR
    Life Sci; 1995; 56(6):PL135-41. PubMed ID: 7530315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated exposure to cocaine alters medial prefrontal cortex dopamine D₂-like receptor modulation of glutamate and dopamine neurotransmission within the mesocorticolimbic system.
    Liu K; Steketee JD
    J Neurochem; 2011 Oct; 119(2):332-41. PubMed ID: 21692802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine.
    Cathala A; Devroye C; Maitre M; Piazza PV; Abrous DN; Revest JM; Spampinato U
    Addict Biol; 2015 May; 20(3):445-57. PubMed ID: 24661380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.
    Culver KE; Szechtman H; Levant B
    Eur J Pharmacol; 2008 Sep; 592(1-3):67-72. PubMed ID: 18644362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin.
    Hernandez L; Lee F; Hoebel BG
    Brain Res Bull; 1987 Dec; 19(6):623-8. PubMed ID: 2449936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia.
    Boulenguez P; Peters SL; Mitchell SN; Chauveau J; Gray JA; Joseph MH
    J Psychopharmacol; 1998; 12(3):258-67. PubMed ID: 10958252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood.
    Cope ZA; Huggins KN; Sheppard AB; Noel DM; Roane DS; Brown RW
    Synapse; 2010 Apr; 64(4):289-300. PubMed ID: 19953655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice.
    Tammimäki A; Pietilä K; Raattamaa H; Ahtee L
    Eur J Pharmacol; 2006 Feb; 531(1-3):118-25. PubMed ID: 16442094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of increased dopamine receptor signaling in food-restricted rats.
    Carr KD; Tsimberg Y; Berman Y; Yamamoto N
    Neuroscience; 2003; 119(4):1157-67. PubMed ID: 12831870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
    Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T
    J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumbal dopamine D2 receptor function is associated with individual variability in ethanol behavioral sensitization.
    Abrahao KP; Quadros IM; Andrade AL; Souza-Formigoni ML
    Neuropharmacology; 2012 Feb; 62(2):882-9. PubMed ID: 21964435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration.
    Finlay JM; Damsma G; Fibiger HC
    Psychopharmacology (Berl); 1992; 106(2):202-8. PubMed ID: 1549647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
    Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.